Nancy U. Lin
Harvard University(US)Dana-Farber Cancer Institute(US)Dana-Farber Brigham Cancer Center(US)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Brain Metastases and Treatment, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies
Most-Cited Works
- → iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics(2017)2,331 cited
- → RECIST 1.1—Update and clarification: From the RECIST committee(2016)1,838 cited
- → Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases(2011)1,412 cited
- → Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment(2019)1,387 cited
- → CNS Metastases in Breast Cancer: Old Challenge, New Frontiers(2013)1,284 cited
- → Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer(2019)1,275 cited